Choosing wisely in oncology: Are we ready for value-based care?

Gabrielle Rocque, Douglas W. Blayney, Mohammad Jahanzeb, August Knape, Merry Jennifer Markham, Trang Pham, Jeremy Shelton, Preeti Sudheendra, Tracey Evans

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Introduction In 2012, ASCO created the Top Five Choosing Wisely (CW) list of low-value tests and procedures for which there is little evidence of benefit. ASCO's Quality Oncology Practice Initiative, an oncologist-led practice-based quality assessment program, includes measures on the basis of these recommendations. Methods CW test measures from spring and fall 2013, spring 2014, and spring 2015 were evaluated for concordance rates, change in the concordance over time, and variability by practice characteristics. Practice characteristics recorded included geographic location, academic affiliation, number of new cases, number of medical oncologists, and rounds of participation in Quality Oncology Practice Initiative. Medians, interquartile ranges, and percentages were calculated for concordance with recommendations and practice characteristics. Change in recommendation concordance over time was assessed using linear regression models. Results From 2013 to 2015, 341 unique oncology practices abstracted the CW measures. Performance varied for specific recommendations. The median concordance was best for measure 1 (patients with low or undocumented performance status who received chemotherapy), where concordance ranged from 78.4% to 83.3%. The lowest concordance was for measure 3 (use of biomarkers or advanced imaging tests for surveillance in early breast cancer), where concordance ranged from 67.7% to 74.2%. Performance on CW measures varied markedly by individual practice. Variability over time and by practice characteristics was observed. Conclusion Performance on ASCO's CW demonstrates room for improvement. Concordance rates varied substantially by practice. Further education on CW measures is needed to improve patient care and enhance value.

Original languageEnglish (US)
Pages (from-to)e935-e943
JournalJournal of Oncology Practice
Volume13
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Linear Models
Geographic Locations
Patient Care
Biomarkers
Breast Neoplasms
Education
Drug Therapy
Oncologists

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Rocque, G., Blayney, D. W., Jahanzeb, M., Knape, A., Markham, M. J., Pham, T., ... Evans, T. (2017). Choosing wisely in oncology: Are we ready for value-based care? Journal of Oncology Practice, 13(11), e935-e943. https://doi.org/10.1200/JOP.2016.019281

Choosing wisely in oncology : Are we ready for value-based care? / Rocque, Gabrielle; Blayney, Douglas W.; Jahanzeb, Mohammad; Knape, August; Markham, Merry Jennifer; Pham, Trang; Shelton, Jeremy; Sudheendra, Preeti; Evans, Tracey.

In: Journal of Oncology Practice, Vol. 13, No. 11, 01.11.2017, p. e935-e943.

Research output: Contribution to journalArticle

Rocque, G, Blayney, DW, Jahanzeb, M, Knape, A, Markham, MJ, Pham, T, Shelton, J, Sudheendra, P & Evans, T 2017, 'Choosing wisely in oncology: Are we ready for value-based care?', Journal of Oncology Practice, vol. 13, no. 11, pp. e935-e943. https://doi.org/10.1200/JOP.2016.019281
Rocque, Gabrielle ; Blayney, Douglas W. ; Jahanzeb, Mohammad ; Knape, August ; Markham, Merry Jennifer ; Pham, Trang ; Shelton, Jeremy ; Sudheendra, Preeti ; Evans, Tracey. / Choosing wisely in oncology : Are we ready for value-based care?. In: Journal of Oncology Practice. 2017 ; Vol. 13, No. 11. pp. e935-e943.
@article{2a18f3e7f0cd4d17b453eb22aa0c27c6,
title = "Choosing wisely in oncology: Are we ready for value-based care?",
abstract = "Introduction In 2012, ASCO created the Top Five Choosing Wisely (CW) list of low-value tests and procedures for which there is little evidence of benefit. ASCO's Quality Oncology Practice Initiative, an oncologist-led practice-based quality assessment program, includes measures on the basis of these recommendations. Methods CW test measures from spring and fall 2013, spring 2014, and spring 2015 were evaluated for concordance rates, change in the concordance over time, and variability by practice characteristics. Practice characteristics recorded included geographic location, academic affiliation, number of new cases, number of medical oncologists, and rounds of participation in Quality Oncology Practice Initiative. Medians, interquartile ranges, and percentages were calculated for concordance with recommendations and practice characteristics. Change in recommendation concordance over time was assessed using linear regression models. Results From 2013 to 2015, 341 unique oncology practices abstracted the CW measures. Performance varied for specific recommendations. The median concordance was best for measure 1 (patients with low or undocumented performance status who received chemotherapy), where concordance ranged from 78.4{\%} to 83.3{\%}. The lowest concordance was for measure 3 (use of biomarkers or advanced imaging tests for surveillance in early breast cancer), where concordance ranged from 67.7{\%} to 74.2{\%}. Performance on CW measures varied markedly by individual practice. Variability over time and by practice characteristics was observed. Conclusion Performance on ASCO's CW demonstrates room for improvement. Concordance rates varied substantially by practice. Further education on CW measures is needed to improve patient care and enhance value.",
author = "Gabrielle Rocque and Blayney, {Douglas W.} and Mohammad Jahanzeb and August Knape and Markham, {Merry Jennifer} and Trang Pham and Jeremy Shelton and Preeti Sudheendra and Tracey Evans",
year = "2017",
month = "11",
day = "1",
doi = "10.1200/JOP.2016.019281",
language = "English (US)",
volume = "13",
pages = "e935--e943",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "11",

}

TY - JOUR

T1 - Choosing wisely in oncology

T2 - Are we ready for value-based care?

AU - Rocque, Gabrielle

AU - Blayney, Douglas W.

AU - Jahanzeb, Mohammad

AU - Knape, August

AU - Markham, Merry Jennifer

AU - Pham, Trang

AU - Shelton, Jeremy

AU - Sudheendra, Preeti

AU - Evans, Tracey

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Introduction In 2012, ASCO created the Top Five Choosing Wisely (CW) list of low-value tests and procedures for which there is little evidence of benefit. ASCO's Quality Oncology Practice Initiative, an oncologist-led practice-based quality assessment program, includes measures on the basis of these recommendations. Methods CW test measures from spring and fall 2013, spring 2014, and spring 2015 were evaluated for concordance rates, change in the concordance over time, and variability by practice characteristics. Practice characteristics recorded included geographic location, academic affiliation, number of new cases, number of medical oncologists, and rounds of participation in Quality Oncology Practice Initiative. Medians, interquartile ranges, and percentages were calculated for concordance with recommendations and practice characteristics. Change in recommendation concordance over time was assessed using linear regression models. Results From 2013 to 2015, 341 unique oncology practices abstracted the CW measures. Performance varied for specific recommendations. The median concordance was best for measure 1 (patients with low or undocumented performance status who received chemotherapy), where concordance ranged from 78.4% to 83.3%. The lowest concordance was for measure 3 (use of biomarkers or advanced imaging tests for surveillance in early breast cancer), where concordance ranged from 67.7% to 74.2%. Performance on CW measures varied markedly by individual practice. Variability over time and by practice characteristics was observed. Conclusion Performance on ASCO's CW demonstrates room for improvement. Concordance rates varied substantially by practice. Further education on CW measures is needed to improve patient care and enhance value.

AB - Introduction In 2012, ASCO created the Top Five Choosing Wisely (CW) list of low-value tests and procedures for which there is little evidence of benefit. ASCO's Quality Oncology Practice Initiative, an oncologist-led practice-based quality assessment program, includes measures on the basis of these recommendations. Methods CW test measures from spring and fall 2013, spring 2014, and spring 2015 were evaluated for concordance rates, change in the concordance over time, and variability by practice characteristics. Practice characteristics recorded included geographic location, academic affiliation, number of new cases, number of medical oncologists, and rounds of participation in Quality Oncology Practice Initiative. Medians, interquartile ranges, and percentages were calculated for concordance with recommendations and practice characteristics. Change in recommendation concordance over time was assessed using linear regression models. Results From 2013 to 2015, 341 unique oncology practices abstracted the CW measures. Performance varied for specific recommendations. The median concordance was best for measure 1 (patients with low or undocumented performance status who received chemotherapy), where concordance ranged from 78.4% to 83.3%. The lowest concordance was for measure 3 (use of biomarkers or advanced imaging tests for surveillance in early breast cancer), where concordance ranged from 67.7% to 74.2%. Performance on CW measures varied markedly by individual practice. Variability over time and by practice characteristics was observed. Conclusion Performance on ASCO's CW demonstrates room for improvement. Concordance rates varied substantially by practice. Further education on CW measures is needed to improve patient care and enhance value.

UR - http://www.scopus.com/inward/record.url?scp=85037140088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037140088&partnerID=8YFLogxK

U2 - 10.1200/JOP.2016.019281

DO - 10.1200/JOP.2016.019281

M3 - Article

C2 - 28783425

AN - SCOPUS:85037140088

VL - 13

SP - e935-e943

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 11

ER -